Abstract
Cardiac disease complicating pregnancy is seen in about 1–4% women. Due to effective treatment during childhood, the incidence of women with heart disease presenting during pregnancy is increasing. In developing countries like India, rheumatic heart disease still predominates, accounting for 60–80% of cardiac lesions in pregnancy. Congenital heart diseases are by far the commonest conditions in the west forming over 75% of heart diseases seen in pregnancy [1]. Pregnancy poses additional problem in women with underlying cardiac disease. A normal heart can adapt well to the hemodynamic alterations of pregnancy, whereas a diseased heart may not be able to do so and decompensate leading to heart failure. Ideally counseling and management of women of childbearing age with cardiac disease should start before pregnancy occurs. High-risk patients should be managed in specialized centers where multidisciplinary care is available. Diagnostic procedures and interventions should ideally be performed prior to pregnancy. Unfortunately in India, many women still are diagnosed to be having cardiac disease for the first time during pregnancy. This increases the morbidity and mortality associated with these disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L, ESC Committee for Practice Guidelines. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147–97.
van Oppen AC, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: a critical review. Obstet Gynecol. 1996;87(2):310–8.
Robson SC, Hunter S, Moore M, et al. Hemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94(11):1028–39.
Robson SC, Dunlop W, Moore M, Hunter S. Combined Doppler and echocardiographic measurement of cardiac output: theory and application in pregnancy. Br J Obstet Gynaecol. 1987;94:1014–27.
Stout KK, Otto CM. Pregnancy in women with valvular heart disease. Heart. 2007;93(5):552–8.
Elkayam U. Pregnancy and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Braunwald's heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia, PA: WB Saunders; 2005. p. 1965–81.
Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520–5.
Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–21.
Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, Vliegen HW, van Dijk AP, Voors AA, Yap SC, van Veldhuisen DJ, Pieper PG. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.
Sawhney H, Aggarwal N, Suri V, Vasishta K, Sharma Y, Grover A. Maternal and perinatal outcome in rheumatic heart disease. Int J Gynaecol Obstet. 2003;80:9–14.
Sawhney H, Suri V, Vasishta K, Gupta N, Devi K, Grover A. Pregnancy and congenital heart disease--maternal and fetal outcome. Aust N Z J Obstet Gynaecol. 1998;38:266–71.
Aggarwal N, Suri V, Kaur H, Chopra S, Rohila M, Vijayvergiya R. Retrospective analysis of outcome of pregnancy in women with congenital heart disease: single-Centre experience from North India. Aust N Z J Obstet Gynaecol. 2009;49:376–81.
Kaur H, Suri V, Aggarwal N, Chopra S, Vijayvergiya R, Talwar KK. Pregnancy in patients with tetralogy of fallot: outcome and management. World J Pediatr Congenit Heart Surg. 2010;1:170–4.
Sikka P, Suri V, Aggarwal N, Chopra S, Bahl A, Vijayverghia R. Are we missing hypertrophic cardiomyopathy in pregnancy? Experience of a tertiary care hospital. J Clin Diagn Res. 2014:13–5.
Suri V, Aggarwal N, Kalpdev A, Chopra S, Sikka P, Vijayvergia R. Pregnancy with dilated and peripartum cardiomyopathy: maternal and fetal outcome. Arch Gynecol Obstet. 2013;287:195–9.
Suri V, Aggarwal N, Keepanasseril A, Chopra S, Vijayvergiya R, Jain S. Pregnancy and Takayasu arteritis: a single Centre experience from North India. J Obstet Gynaecol Res. 2010;36:519–24.
Suri V, Keepanasseril A, Aggarwal N, Vijayvergiya R, Chopra S, Rohilla M. Maternal complete heart block in pregnancy: analysis of four cases and review of management. J Obstet Gynaecol Res. 2009;35:434–7.
van Hagen IM, Boersma E, Johnson MR, Thorne SA, Parsonage WA, Escribano Subías P, Leśniak-Sobelga A, Irtyuga O, Sorour KA, Taha N, Maggioni AP, Hall R, Roos-Hesselink JW, ROPAC investigators and EORP team. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: results of a registry from the European Society of Cardiology. Eur J Heart Fail. 2016;18:523–33.
Sugrue D, Blake S, Troy P, et al. Antibiotic prophylaxis against infective endocarditis after normal delivery--is it necessary? Br Heart J. 1980;44(5):499–502.
McFaul PB, Dornan JC, Lamki H, et al. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol. 1988 Sep.;95(9):861–7.
Petanovic M, Zagar Z. The significance of asymptomatic bacteremia for the newborn. Acta Obstet Gynecol Scand. 2001;80(9):813–7.
Nishimura RA, Otto CM, Bonow RO, Carrabillo BA, Erwin JP, et al. Practice guideline. J Am Cardiol. 2014;63:e 57–185.
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, et al. ESC guidelines for the management of infective endocarditis: the task force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.
Aggarwal N, Suri V, Goyal A, Malhotra S, Manoj R, Dhaliwal RS. Closed mitral valvotomy in pregnancy and labor. Int J Gynaecol Obstet. 2005;88:118–21.
Chopra S, Suri V, Aggarwal N, Rohilla M, Vijayvergiya R, Keepanasseril A. Ebstein's anomaly in pregnancy: maternal and neonatal outcomes. J Obstet Gynaecol Res. 2010;36:278–83.
Suri V, Keepanasseril A, Aggarwal N, Chopra S, Bagga R, Sikka P, Vijayvergiya R. Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experience. Eur J Obstet Gynecol Reprod Biol. 2011;159:320–3.
Suri V, Sawhney H, Vasishta K, Renuka T, Grover A. Pregnancy following cardiac valve replacement surgery. Int J Gynaecol Obstet. 1999;64:239–46.
Nishimura RA, Warnes CA. Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions. Heart. 2015;101:430–5.
Saha PK, Joshi B, Suri V, Vijayvergiya R, Sikka P, Aggarwal N, Chopra S. Mitral valve thrombosis in pregnancy: successful restoration with thrombolysis. Am J Emerg Med. 2015;33:1325.e1–2.
Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, et al. Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, et al. Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.
Suri V, Aggarwal N, Kaur R, Chaudhary N, Ray P, Grover A. Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease. Contraception. 2008 Oct;78(4):315–8.
World Health Organization. Medical eligibility criteria for contraceptive use. 5th ed; 2015.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Suri, V., Sikka, P. (2020). Heart Disease. In: Sharma, A. (eds) Labour Room Emergencies. Springer, Singapore. https://doi.org/10.1007/978-981-10-4953-8_8
Download citation
DOI: https://doi.org/10.1007/978-981-10-4953-8_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4952-1
Online ISBN: 978-981-10-4953-8
eBook Packages: MedicineMedicine (R0)